Sign in
0J2O Stock Price, Chart, Stats & News
Halozyme Therapeutics, Inc.
Save
Halozyme Therapeutics, Inc. (0J2O) does not currently pay a dividend.
8.99B
Market cap
18.41x
Current P/E
–
Forward P/E
0J2O chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Halozyme Therapeutics, Inc., a biopharmaceutical technology company, was established in 1998 and is based in San Diego, California. The company's operations span globally, covering markets in the United States, Switzerland, Ireland, Belgium, and Japan. At the heart of Halozyme's offerings is its patented ENHANZE drug delivery technology.
Similar securities
Based on sector and market capitalization
Report issue